
|Articles|September 18, 2014
- Melanoma (Issue 3)
- Volume 3
- Issue 1
Immunotherapy Combinations for the Treatment of Melanoma
Author(s)Mario Sznol, MD
Mario Sznol, MD, professor, Internal Medicine, Yale Cancer Center, discusses the potential for immunotherapy combinations for the treatment of melanoma.
Advertisement
Mario Sznol, MD, professor, Internal Medicine, Yale Cancer Center, discusses the potential for immunotherapy combinations for the treatment of melanoma.
Read about checkpoint strategies for the treatment of melanoma > >
Articles in this issue
over 11 years ago
Inducing an Immune Response With a Patient’s Tumorover 11 years ago
Partnering T-VEC With a Targeted Agent for the Treatment of MelanomaAdvertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
3
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
4
Illuminating the Sequence of Third-Line Therapies in Metastatic CRC
5










































